Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-10

Clinical Trial Update: Semaglutide in Auto-HSCT [Phase 2]

View source ↗

Summary

Phase 2 trial update for semaglutide in autologous hematopoietic stem cell transplantation addressing intestinal mucositis and related inflammation; currently n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • semaglutide (semaglutide)

Snippet

Sponsor: Klaus Gottlob Müller | Conditions: Intestinal Mucositis, Inflammation | Phase 2 | Status: NOT_YET_RECRUITING